Literature DB >> 9324076

Biochemical and genetic studies in a family with mitochondrial myopathy.

T D Heiman-Patterson1, Z Argov, J M Chavin, B Kalman, H Alder, S DiMauro, W Bank, A J Tahmoush.   

Abstract

We present a family with severe exercise intolerance, progressive proximal weakness, and lactic acidemia. Fifteen of 24 family members in five generations were affected. Since the affected males do not have offspring at this time, the family pedigree is consistent with either maternal or autosomal dominant inheritance. Muscle histochemistry showed ragged-red fibers and electron microscopy showed globular mitochondrial inclusions. Biochemical analysis showed reduced muscle activities of mitochondrial NADH-cytochrome c reductase (1 of 2 patients), succinate-cytochrome c reductase (2 patients), and cytochrome c oxidase (2 patients). For 1 patient, sequence analysis of 44% of the muscle mitochondrial DNA including all 22 transfer RNA regions showed no point mutation with pathogenic significance. Southern blot analysis showed no deletion. Six affected members of the family were treated with methylprednisolone (0.25 mg/kg) for 3 months. Muscle strength, serum lactate, and energy metabolism at rest (measured by 31P magnetic resonance spectroscopy) significantly improved with treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324076     DOI: 10.1002/(sici)1097-4598(199710)20:10<1219::aid-mus2>3.0.co;2-f

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Glucocorticoids for mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 2.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy.

Authors:  Mario K Shammas; Xiaoping Huang; Beverly P Wu; Evelyn Fessler; Insung Y Song; Nicholas P Randolph; Yan Li; Christopher Ke Bleck; Danielle A Springer; Carl Fratter; Ines A Barbosa; Andrew F Powers; Pedro M Quirós; Carlos Lopez-Otin; Lucas T Jae; Joanna Poulton; Derek P Narendra
Journal:  J Clin Invest       Date:  2022-07-15       Impact factor: 19.456

4.  Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy.

Authors:  Senda Ajroud-Driss; Faisal Fecto; Kaouther Ajroud; Irfan Lalani; Sarah E Calvo; Vamsi K Mootha; Han-Xiang Deng; Nailah Siddique; Albert J Tahmoush; Terry D Heiman-Patterson; Teepu Siddique
Journal:  Neurogenetics       Date:  2014-09-06       Impact factor: 2.660

5.  Quantitative in vivo magnetic resonance spectroscopy using synthetic signal injection.

Authors:  Kenneth I Marro; Donghoon Lee; Eric G Shankland; C Mark Mathis; Cecil E Hayes; Seth D Friedman; Martin J Kushmerick
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

Review 6.  The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence.

Authors:  Allison Hanaford; Simon C Johnson
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.